Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-022-05065-4, published online 14 July 2022
The original version of this article contained a mistake in figure 4. There was an error in figure 4H. In these wound healing assays, the figure in group “Pictilisib + Semaphorin 5A” was mistakenly repeated with that in group “MK-2206+Semaphorin 5A” at 24h! The authors apologize for this mistake. There is no impact on the final conclusions. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cheng, Q., Chen, M., Liu, M. et al. Correction: Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death Dis 14, 196 (2023). https://doi.org/10.1038/s41419-023-05697-0
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-023-05697-0
This article is cited by
-
Integrated analysis and validation of ferroptosis-related genes and immune infiltration in acute myocardial infarction
BMC Cardiovascular Disorders (2024)
